ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines

British Journal of Cancer

Volumn 108, Issue 10, 2013, Pages 2056-2062

  Khursheed, M ^a   Kolla, J N ^a   Kotapalli, V ^a   Gupta, N ^a   Gowrishankar, S ^b   Uppin, S G ^c   Sastry, R A ^c,e   Koganti, S ^c   Sundaram, C ^c   Pollack, J R ^d   Bashyam, M D ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b APOLLO HOSPITAL   (India)

^c NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e KRISHNA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AT RICH INTERACTION DOMAIN 1B PROTEIN; AZACITIDINE; DNA; RETINOBLASTOMA BINDING PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA METHYLATION; DRUG EFFECT; GENE REPRESSION; IMMUNOHISTOCHEMISTRY; LIQUID CULTURE; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84878600534     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.200     Document Type: Article

References (37)

1. Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909.
2. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JR (2005) Array-based comparative genomic hybridisation identifies localised DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7: 556-562.
3. Birnbaum DJ, Adelaide J, Mamessier E, Finetti P, Lagarde A, Monges G, Viret F, Goncalves A, Turrini O, Delpero JR, Iovanna J, Giovannini M, Birnbaum D, Chaffanet M (2011) Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer 50: 456-465.
4. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA (2010) Accumulation of driver and passenger mutations during tumour progression. Proc Natl Acad Sci USA 107: 18545-18550.
5. Buchler M, Friess H, Schultheiss KH, Gebhardt C, Kubel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M, Muller G, Schulz G, Beger HG (1991) A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68: 1507-1512.
6. Caramel J, Medjkane S, Quignon F, Delattre O (2008) The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumours. Oncogene 27: 2035-2044.
7. DelBove J, Rosson G, Strobeck M, Chen J, Archer TK, Wang W, Knudsen ES, Weissman BE (2011) Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumour suppressor gene. Epigenetics 6: 1444-1453.
8. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130.
9. Flores-Alcantar A, Gonzalez-Sandoval A, Escalante-Alcalde D, Lomeli H (2011) Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle. Cell Tissue Res 345: 137-148.
10. Ginestier C, Charafe-Jauffret E, Bertucci F, Eisinger F, Geneix J, Bechlian D, Conte N, Adelaide J, Toiron Y, Nguyen C, Viens P, Mozziconacci MJ, Houlgatte R, Birnbaum D, Jacquemier J (2002) Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumour markers. Am J Pathol 161: 1223-1233.
11. Inoue H, Furukawa T, Giannakopoulos S, Zhou S, King DS, Tanese N (2002) Largest subunits of the human SWI/SNF chromatin-remodelling complex promote transcriptional activation by steroid hormone receptors. J Biol Chem 277: 41674-41685.
12. Inoue H, Giannakopoulos S, Parkhurst CN, Matsumura T, Kono EA, Furukawa T, Tanese N (2011) Target genes of the largest human SWI/SNF complex subunit control cell growth. Biochem J 434: 83-92.
13. Kaeser MD, Aslanian A, Dong MQ, Yates JR, Emerson BM (2008) BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 283: 32254-32263.
14. Kennison JA (1995) The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 29: 289-303.
15. Kim S, Chin K, Gray JW, Bishop JM (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumour suppressor gene in human cancer. Proc Natl Acad Sci USA 101: 16251-16256.
16. Kucuk C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivistava G, Au WY, McKeithan TW, Chan WC (2011) PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA 108: 20119-20124.
17. Kwei KA, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, van de Rijn M, Maitra A, Pollack JR (2008) Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet 4: e1000081.
18. Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD, Pollack JR (2011) SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One 6: e23924.
19. Mamo A, Cavallone L, Tuzmen S, Chabot C, Ferrario C, Hassan S, Edgren H, Kallioniemi O, Aleynikova O, Przybytkowski E, Malcolm K, Mousses S, Tonin PN, Basik M (2012) An integrated genomic approach identifies ARID1A as a candidate tumour-suppressor gene in breast cancer. Oncogene 31: 2090-2100.
20. Mazurenko NN, Beliakov IS, Bliev A, Guo Z, Hu X, Vinokurova SV, Bidzhieva BA, Pavlova LS, Ponten J, Kiselev FL (2003) [Cervical carcinoma progression-associated genetic alterations on chromosome 6]. Mol Biol (Mosk) 37: 472-481.
21. Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD (2002) HLTF gene silencing in human colon cancer. Proc Natl Acad Sci USA 99: 4562-4567.
22. Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B, RoggendorfW(2008) Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182: 18-26.
23. Nagl Jr. NG, Wang X, Patsialou A, Van Scoy M, Moran E (2007) Distinct mammalian SWI/SNF chromatin remodelling complexes with opposing roles in cell-cycle control. Embo J 26: 752-763.
24. Napolitano MA, Cipollaro M, Cascino A, Melone MA, Giordano A, Galderisi U (2007) Brg1 chromatin remodelling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells. J Cell Sci 120: 2904-2911.
25. Ouyang H, Mou L, Luk C, Liu N, Karaskova J, Squire J, Tsao MS (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157: 1623-1631.
26. Rosson GB, Bartlett C, Reed W, Weissman BE (2005) BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. J Cell Physiol 205: 286-294.
27. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G (2007) Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745.
28. Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR (2012) Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumour suppressive complex in pancreatic cancer. Proc Natl Acad Sci USA 109: E252-E259.
29. Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y, Emi M (2000) Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas. Cancer 88: 1410-1416.
30. Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S (2005) The BRG1-and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumour suppressor gene. Mol Cell Biol 25: 7953-7965.
31. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR (1996) Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10: 2117-2130.
32. Weissman B, Knudsen KE (2009) Hijacking the chromatin remodelling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res 69: 8223-8230.
33. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih Ie, M, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532-1543.
34. Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492.
35. Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CW (2010) Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18: 316-328.
36. Xi Q, He W, Zhang XH, Le HV, Massague J (2008) Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem 283: 1146-1155.
37. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K, Wang W (2005) PBAF chromatin-remodelling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferonresponsive genes. Genes Dev 19: 1662-1667.